UNSPSC 85502952: Supplement right external carotid artery with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right external carotid artery with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03UM37Z

UNSPSC 85502952 Supplement right external carotid artery with autologous tissue substitute, percutaneous approach is a Commodity code with no recent state and local contract opportunities matching its medical-device or surgical-procedure scope. The recent opportunities posted under this code reflect an administrative misclassification — the actual solicitations cover occupational medical surveillance, disability medical evaluations, pharmacy benefit management, surgical carve-out networks, temporary health professional staffing, and youth detention healthcare services, none of which align with the vascular surgical intervention the code nominally describes. State and local procurement offices appear to have applied this code to a broad range of health services and benefits administration work rather than to the specific procedure the code defines.

The geographic spread of recent activity includes Arizona (City of Phoenix), California (Long Beach and Santa Clara County), Washington State (Department of Transportation), Florida (Collier County), and Texas (Harris County), though the misclassification makes it unclear whether this code represents a systematic market segment or a data-tagging anomaly. Representative recent solicitations include the City of Phoenix Retirement Office RFP for independent medical evaluation services (posted September 16, 2026, responses due October 16, 2026) and the Washington State Department of Transportation RFP for occupational medical surveillance across 14 ferry locations (posted August 25, 2026, responses due October 9, 2026). Given the mismatch between the code's nominal scope and the actual work being tagged, this code does not represent a coherent procurement activity for vendors in vascular surgery, surgical implants, or tissue substitute products.